摘要 |
The present invention provides isoxazole derivatives represented by the following formula (I): (wherein R<SUP>1 </SUP>represents a hydrogen atom, C<SUB>1</SUB>-C<SUB>20 </SUB>hydrocarbon group or -C(-O)OR<SUP>1a </SUP>(wherein R<SUP>1a </SUP>represents a C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl group, etc.); R<SUP>2 </SUP>and R<SUP>3 </SUP>represent a hydrogen atom, halogen atom, hydroxy group, C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl group or C<SUB>6</SUB>-C<SUB>20 </SUB>aryl group, etc.; R<SUP>4 </SUP>represents a hydrogen atom, halogen atom, hydroxy group, cyano group, nitro group, amino group, C<SUB>1</SUB>-C<SUB>20 </SUB>hydrocarbon group, C<SUB>1</SUB>-C<SUB>10 </SUB>alkoxy group, C<SUB>1</SUB>-C<SUB>10 </SUB>acyl group, 5- to 7-membered heterocyclic group, etc.; R<SUP>5 </SUP>represents a hydrogen atom, halogen atom, hydroxy group, optionally substituted C<SUB>1</SUB>-C<SUB>20 </SUB>hydrocarbon group, C<SUB>1</SUB>-C<SUB>20 </SUB>alkoxy group, 5- to 7-membered heterocyclic group, etc.; and, n represents 0, 1, 2, 3 or 4), and a process of producing the same. The compounds are useful as intermediates for synthesis of pharmaceutical compounds, agricultural chemicals, dye compounds, etc. having the isoxazole skeleton.
|